Structured Discussion: What Counts as Validation for a Patient World Model?
Emma Slade
Abstract
Moderated by Emma Slade, Senior Director of AI/ML, GSK. Discussion of historical trial emulation, synthetic controls, uncertainty, causal validity, generalisation, and clinical utility.
Chat is not available.
Successful Page Load